Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole plus Deanxit versus esomeprazole alone for GERD with emotional disorders
ChiCTR-TRC-12002101Phase 4Completed
- Sponsor
- Trauma Center of Daping Hospital, Army Military Medical University
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of flupentixol + melitracen and esomeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Trauma Center of Daping Hospital, Army Military Medical University. Primary endpoint: GerdQ. Started Oct 2011; status: completed.
02
Drugs
flupentixol + melitracenesomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on ChiCTR-TRC-12002101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002101.